[Age-related metabolic development in rats: insulin's role]

Bessem Mornagui1, Abir Grissa, Fazaa Saloua El

  • 1Laboratoire de Physiologie Animale, Département de Biologie, Faculté des Sciences de Tunis, Tunisie.

La Tunisie Medicale
|November 10, 2004
PubMed

Insights

This study tracked metabolic and hormonal changes in Wistar rats from fetus to adult. Key shifts in carbohydrates, lipids, proteins, and insulin occur significantly at birth and weaning.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Developmental Biology

Context:

  • Understanding metabolic and hormonal shifts during development is crucial for identifying normal physiological changes and potential disruptions.
  • Wistar rats serve as a common model organism for studying mammalian development and metabolism.

Purpose:

  • To investigate developmental changes in plasma and hepatic concentrations of carbohydrates, lipids, and proteins in Wistar rats.
  • To examine the evolution of insulin levels throughout the developmental stages, from prenatal to adult.
  • To correlate these biochemical and hormonal changes with specific developmental milestones such as birth and weaning.

Summary:

  • Fetal rats (day 21) exhibited lower glycemia, higher hepatic glycogen, and reduced plasma/hepatic lipids and proteins compared to adults (day 133), with significantly higher fetal insulinemia.
  • Post-birth, glycemia increased, hepatic glycogen depleted, plasma/hepatic lipids and proteins rose, and insulin levels dropped sharply.
  • During postnatal days 14-30 (weaning), hepatic glycogen and glycemia normalized, plasma/hepatic proteins increased, lipids decreased, and insulin levels rose, stabilizing in adulthood.

Impact:

  • Provides a comprehensive timeline of key metabolic and hormonal adaptations during rat development.
  • Highlights critical periods of metabolic and endocrine transition, particularly around birth and weaning.
  • Establishes baseline physiological data for Wistar rats, valuable for future research on developmental disorders and metabolic diseases.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...